1. AstraZeneca Pharma Ind
stock logo

AstraZeneca Pharma Ind Share Price

ASTRAZEN

₹7,351.45-₹199.50 (-2.64%) TodayLast updated on 04 Nov, 2024 | 15:51 IST

AstraZeneca Pharma Ind Share Price Chart

Please wait...
  • About AstraZeneca Pharma Ind
  • Fundamentals
  • Events
  • More
  • News

About AstraZeneca Pharma Ind

AstraZeneca Pharma Ind Financials

arrow
Market cap
Market Cap Switch₹19,062 Crs
Open
₹7,550.00
Close
₹7,550.95
Circuit range
₹8,821.70 - ₹5,881.20
Day range
₹7,215.55 - ₹7,550.00
Year range
₹4,510.00 - ₹8,139.00
Volume
11,789
Avg. traded
₹7,415.01
Revenue (12m)
₹1,388 Crs
AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

Astrazeneca Pharma Ind Key indicators

arrow
52 week high
₹8,139.00
52 week low
₹4,510.00
P/E ratio
198.86
P/B ratio
26.52
ROE
24.95%
ROCE
33.94%
Dividend yield
0.32%
Debt/Equity ratio
EPS
64.6

Learn more

Investment checklist: (5/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

AstraZeneca Pharma Ind Fundamentals

AstraZeneca Pharma Ind Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

16.84%

Net profit margin

12.4%

ROE

24.95%

ROA

13.35%

ROCE

33.94%

Learn more

AstraZeneca Pharma Ind Shareholder returns

arrow
1 day
-2.64%
1 week
+4.12%
1 month
-1.15%
3 months
+4.43%
1 year
+57.56%
3 years
+141.00%
5 years
+179.30%

Astrazeneca Pharma Ind Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹7,550.00
₹7,351.45
-2.64%
Fri, Nov 1 2024
₹7,600.00
₹7,550.95
-0.97%
Thu, Oct 31 2024
₹7,305.00
₹7,624.90
+3.89%
Wed, Oct 30 2024
₹7,340.70
₹7,339.10
-0.01%
Tue, Oct 29 2024
₹7,088.25
₹7,340.00
+3.95%
Mon, Oct 28 2024
₹7,142.20
₹7,060.80
-1.14%
Fri, Oct 25 2024
₹7,155.05
₹7,142.20
-0.18%
Thu, Oct 24 2024
₹7,223.25
₹7,155.25
-0.94%

AstraZeneca Pharma Ind Shareholding Pattern

arrow

Promoters (75%)

Mutual Funds (5.05%)

Retail and other (17.01%)

Foreign institutions-FII (2.9%)

Other domestic institutions (0.05%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹24/share

    Ex date 05 Jul 2024

    expand tab
  • Dividend • ₹16/share

    Ex date 14 Jul 2023

    expand tab
  • Dividend • ₹8/share

    Ex date 07 Jul 2022

    expand tab

Learn more

FAQs on AstraZeneca Pharma Ind